A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation
Condition:   Irritable Bowel Syndrome Characterized by Constipation Interventions:   Drug: Linaclotide;   Drug: Placebo Sponsors:   Ironwood Pharmaceuticals, Inc.;   Allergan Sales, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2018 Category: Research Source Type: clinical trials

A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation
Condition:   Irritable Bowel Syndrome Characterized by Constipation Interventions:   Drug: Linaclotide;   Drug: Placebo Sponsors:   Ironwood Pharmaceuticals, Inc.;   Allergan Sales, LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2018 Category: Research Source Type: clinical trials

A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation
Condition:   Irritable Bowel Syndrome Characterized by Constipation Interventions:   Drug: Linaclotide;   Drug: Placebo Sponsors:   Ironwood Pharmaceuticals, Inc.;   Allergan Sales, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2018 Category: Research Source Type: clinical trials

Changes in Microbiota and Metabolomic Profile Between Rifaximin Responders and Non-responders In Diarrhoea-Predominant Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome With Diarrhea Intervention:   Drug: Rifaximin Oral Tablet Sponsors:   National University Hospital, Singapore;   National University, Singapore Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 15, 2018 Category: Research Source Type: clinical trials

TReatment of Irritable Bowel Syndrome With Diarrhoea Using Titrated ONdansetron Trial
Condition:   IBS - Irritable Bowel Syndrome Intervention:   Drug: Ondansetron Sponsors:   University of Leeds;   Barnsley Hospital NHS Foundation Trust;   Barts & The London NHS Trust;   County Durham and Darlington NHS Foundation Trust;   Flinders University;   The Leeds Teaching Hospitals NHS Trust;   London North West Healthcare NHS Trust;   Lothian Health Board;   Queen Mary Univ...
Source: ClinicalTrials.gov - June 13, 2018 Category: Research Source Type: clinical trials

Multicenter Observational Prospective Study to Describe Irritable Bowel Syndrome in the Russian Federation
Condition:   Irritable Bowel Syndrome Intervention:   Other: IBS Sponsor:   Abbott Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 7, 2018 Category: Research Source Type: clinical trials